Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
The Korean Journal of Internal Medicine ; : 133-141, 2020.
Article | WPRIM | ID: wpr-831767

ABSTRACT

There is insufficient quality data to recommend the use of herbs for the treatment of acute bronchitis. Small number of randomized trials of plant extracts for this purpose were determined to be low quality and there are concerns for the safety. HL301 is a combined product of seven medicinal plants. In the present study, we tried to evaluate the efficacy and safety of HL301 for the treatment of acute bronchitis with a randomized, double-blind, placebo-controlled, multicenter trial design. Methods: A total of 166 patients with acute bronchitis were randomized to receive placebo or HL301 (600 mg/day) for 7 days. The primary endpoint was change in bronchitis severity score (BSS) from baseline visit (visit 2) to the end of treatment (visit 3). Other efficacy variables were the change of each component of the BSS (cough, sputum, dyspnea, chest pain, and crackle) with treatment, response rate, improvement rate, satisfaction rate and number of rescue medications taken. Results: Changes in the BSS from visit 2 to visit 3 were higher in the HL301 group than in the placebo group both in the full analysis set (4.57 ± 1.82 vs. 3.15 ± 3.08, p < 0.01) and in the per protocol set (4.62 ± 1.81 vs. 3.30 ± 3.03, p < 0.01). Four BSS components (cough, sputum, dyspnea, and chest pain) improved more with HL301 treatment than with placebo treatment. Participants treated with HL301 showed higher response, improvement, and satisfaction rates and less use of rescue medication than the placebo group. Conclusions: HL301 (600 mg/day) was effective and safe for symptomatic treatment of acute bronchitis.

2.
The Korean Journal of Internal Medicine ; : 941-951, 2018.
Article in English | WPRIM | ID: wpr-717188

ABSTRACT

BACKGROUND/AIMS: To use serological and multiplex polymerase chain reaction (PCR) assays to examine sputum samples from patients experiencing acute exacerbation of chronic obstructive pulmonary disease (AECOPD) for the presence of atypical pathogens, including Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila. METHODS: From September 2012 to February 2014, 341 patients with AECOPD attending outpatient clinics were enrolled as part of a randomized, double-blind, multicenter study. A commercial enzyme-linked immunosorbent assay was used to measure serum immunoglobulin M (IgM) and IgG antibody titers on the first day of the study and at 36 days post-enrollment. Multiplex PCR was used to test sputum samples for the presence of atypical pathogens. A urinary antigen test for L. pneumophila was performed on the first day. RESULTS: Nineteen patients (5.6%) showed serological evidence of acute infection with M. pneumoniae. Also, one and seven patients (2%) showed serological evidence of acute infection with C. pneumoniae and L. pneumophila, respectively. All DNA samples were negative for M. pneumoniae, C. pneumoniae, and L. pneumophila according to PCR. Only one urine sample was positive for L. pneumophila antigen, but serologic evidence was lacking. CONCLUSIONS: Serological testing suggested that infection by atypical pathogens during AECOPD was relatively uncommon. In addition, PCR provided no direct evidence of infection by atypical pathogens. Thus, atypical pathogens may not be a major cause of AECOPD in South Korea.


Subject(s)
Humans , Ambulatory Care Facilities , Chlamydophila pneumoniae , DNA , Enzyme-Linked Immunosorbent Assay , Immunoglobulin G , Immunoglobulin M , Korea , Legionella pneumophila , Multiplex Polymerase Chain Reaction , Mycoplasma pneumoniae , Pneumonia , Pneumonia, Mycoplasma , Polymerase Chain Reaction , Pulmonary Disease, Chronic Obstructive , Serologic Tests , Sputum
3.
Tuberculosis and Respiratory Diseases ; : 148-155, 2018.
Article in English | WPRIM | ID: wpr-713767

ABSTRACT

BACKGROUND: Although targeted therapy and immuno-oncology have shifted the treatment paradigm for lung cancer, platinum-based combination is still the standard of care for advanced non-small cell lung cancer (NSCLC). Pemetrexed continuation maintenance therapy has been approved and increasingly used for patients with nonsquamous NSCLC. However, the efficacy of this strategy has not been proven in patients without driving mutations. The objective of this study was to compare the clinical benefit of pemetrexed continuation maintenance to conventional platinum-based doublet in epidermal growth factor receptor (EGFR)-negative lung adenocarcinoma. METHODS: A total of 114 patients with EGFR-negative lung adenocarcinoma who were treated with platinum doublet were retrospectively enrolled. We compared the survival rates between patients received pemetrexed maintenance after four-cycled pemetrexed/cisplatin and those received at least four-cycled platinum doublet without maintenance chemotherapy as a first-line treatment. RESULTS: Forty-one patients received pemetrexed maintenance and 73 received conventional platinum doublet. Median progression-free survival (PFS), which was defined as the time from the day of response evaluation after four cycles of chemotherapy to disease progression or death, was significantly higher in the pemetrexed maintenance group compared to conventional group (5.8 months vs. 2.2 months, p<0.001). Median overall survival showed an increasing trend in the pemetrexed maintenance group (22.3 months vs. 16.1 months, p=0.098). Multivariate analyses showed that pemetrexed maintenance chemotherapy was associated with better PFS (hazard ratio, 0.73; 95% confidence interval, 0.15–0.87). CONCLUSION: Compared to conventional platinum-based chemotherapy, premetrexed continuation maintenance treatment is associated with better clinical outcome for the patients with EGFR wild-type lung adenocarcinoma.


Subject(s)
Humans , Adenocarcinoma , Carcinoma, Non-Small-Cell Lung , Disease Progression , Disease-Free Survival , Drug Therapy , Lung Neoplasms , Lung , Maintenance Chemotherapy , Multivariate Analysis , Pemetrexed , Platinum , ErbB Receptors , Retrospective Studies , Standard of Care , Survival Rate
4.
The Korean Journal of Internal Medicine ; : 182-185, 2017.
Article in English | WPRIM | ID: wpr-49974

ABSTRACT

No abstract available.


Subject(s)
Bilirubin , Ethiodized Oil , Fistula , Urinalysis
5.
The Ewha Medical Journal ; : 125-128, 2016.
Article in English | WPRIM | ID: wpr-84898

ABSTRACT

Uremic pleuritis is a fibrinous pleuritis of unknown pathogenesis in patients with chronic kidney disease. Although it responds to regular dialysis or repeated thoracentesis, cases that are refractory to those therapies have been reported. We report a case of uremic pleuritis which showed marked improvement following corticosteroid therapy. The effusion was exudate, and negative in cytology and microbiology. Pleural biopsy revealed chronic inflammation with fibrosis. The pleural effusion did not respond to chest tube drainage and continuance of hemodialysis. With a diagnosis of refractory uremic pleuritis, we started methylprednisolone. The pleural effusion responded to the treatment and resolved without complication.


Subject(s)
Humans , Biopsy , Chest Tubes , Diagnosis , Dialysis , Drainage , Exudates and Transudates , Fibrin , Fibrosis , Inflammation , Methylprednisolone , Pleural Effusion , Pleurisy , Renal Dialysis , Renal Insufficiency, Chronic , Thoracentesis , Uremia
6.
Laboratory Medicine Online ; : 219-222, 2015.
Article in Korean | WPRIM | ID: wpr-128362

ABSTRACT

Melioidosis, which is an infectious disease caused by Burkholderia pseudomallei, is prevalent mostly in Southeast Asia and northern Australia; it can progress to abscess formation, pneumonia and sepsis, and ultimately cause death. A 66-yr-old male patient with diabetes mellitus was hospitalized for sepsis 3 months after coming back from Cambodia, and B. pseudomallei was identified from the blood culture. The B. pseudomallei strain was found to be susceptible to carbapenem, and non-susceptible to trimethoprim/sulfamethoxazole and ceftazidime. Although the patient was treated with carbapenem, to which the strain was susceptible, the bacteremia persisted, and progressed to septic shock and pneumonia, and eventually to acute respiratory distress syndrome (ARDS). The patient died on the 12th day of hospitalization. This study, which reports the first case of ceftazidime-nonsusceptible B. pseudomallei in Korea, indicates the importance of B. pseudomallei infection, which is highly likely to be imported to Korea, and discuss its clinical progress, which can lead to fatality.


Subject(s)
Humans , Male , Abscess , Asia, Southeastern , Australia , Bacteremia , Burkholderia pseudomallei , Burkholderia , Cambodia , Ceftazidime , Communicable Diseases , Diabetes Mellitus , Hospitalization , Korea , Melioidosis , Pneumonia , Respiratory Distress Syndrome , Sepsis , Shock, Septic
7.
Korean Journal of Medicine ; : S199-S203, 2011.
Article in Korean | WPRIM | ID: wpr-209158

ABSTRACT

It is very rare for an exocervical adenocarcinoma to metastasize to the lung parenchyma and pleura. A 54-year-old woman was admitted with dyspnea and left pleural effusion on chest X-ray. She had a history of exocervical adenocarcinoma 3 years previously and was treated with hysterectomy, chemotherapy, and radiation therapy. Last year, she was diagnosed with a left vestibular schwannoma and underwent subtotal mass removal surgery. After admission, metastatic adenocarcinoma of the pleura was diagnosed by video-assisted thoracic surgery biopsy. We herein report the rare case of exocervical adenocarcinoma that presented as a metastatic lesion to the pleura 3 years after the initial diagnosis.


Subject(s)
Female , Humans , Middle Aged , Adenocarcinoma , Biopsy , Dyspnea , Hysterectomy , Lung , Neoplasm Metastasis , Neuroma, Acoustic , Pleura , Pleural Effusion , Pleural Neoplasms , Recurrence , Thoracic Surgery, Video-Assisted , Thorax
8.
Tuberculosis and Respiratory Diseases ; : 199-205, 2011.
Article in Korean | WPRIM | ID: wpr-169155

ABSTRACT

Social welfare services for respiratory-disabled persons in Korea are offered based on the respiratory impairment grade, which is determined by 3 clinical parameters; dyspnea, forced expiratory volume in 1 second (FEV1), and arterial oxygen tension. This grading system has several limitations in the objective assessment of respiratory impairment. We reviewed several guidelines for the evaluation of respiratory impairment and relevant articles. Then, we discussed a new grading system with respiratory physicians. Both researchers and respiratory physicians agreed that pulmonary function tests are essential in assessing the severity of respiratory impairment, forced vital capacity (FVC), FEV1 and single breath diffusing capacity (DLco) are the primarily recommended tests. In addition, we agreed that arterial blood gas analysis should be reserved for selected patients. In conclusion, we propose a new respiratory impairment grading system utilizing a combination FVC, FEV1 and DLco scores, with more social discussion included.


Subject(s)
Humans , Blood Gas Analysis , Disability Evaluation , Dyspnea , Forced Expiratory Volume , Korea , Oxygen , Pulmonary Diffusing Capacity , Respiratory Function Tests , Respiratory System , Social Welfare , Spirometry , Vital Capacity
9.
Korean Journal of Medicine ; : 775-779, 2011.
Article in Korean | WPRIM | ID: wpr-143830

ABSTRACT

Tuberous sclerosis is an autosomal dominant disorder characterized by facial skin lesions, epilepsy, and mental retardation. Pulmonary involvement in tuberous sclerosis is rare and shows characteristic reticulonodular infiltration and cystic changes. Lymphangioleiomyomatosis is characterized by the progressive proliferation of smooth muscle cells and occurs in 0.1-1% of patients with tuberous sclerosis. We encountered a case of pulmonary lymphangioleiomyomatosis associated with tuberous sclerosis and bilateral renal angiomyolipoma in a 31-year-old female patient. This case is reported here along with a brief review of the literature.


Subject(s)
Adult , Female , Humans , Angiomyolipoma , Epilepsy , Intellectual Disability , Lymphangioleiomyomatosis , Myocytes, Smooth Muscle , Skin , Tuberous Sclerosis
10.
Korean Journal of Medicine ; : 775-779, 2011.
Article in Korean | WPRIM | ID: wpr-143823

ABSTRACT

Tuberous sclerosis is an autosomal dominant disorder characterized by facial skin lesions, epilepsy, and mental retardation. Pulmonary involvement in tuberous sclerosis is rare and shows characteristic reticulonodular infiltration and cystic changes. Lymphangioleiomyomatosis is characterized by the progressive proliferation of smooth muscle cells and occurs in 0.1-1% of patients with tuberous sclerosis. We encountered a case of pulmonary lymphangioleiomyomatosis associated with tuberous sclerosis and bilateral renal angiomyolipoma in a 31-year-old female patient. This case is reported here along with a brief review of the literature.


Subject(s)
Adult , Female , Humans , Angiomyolipoma , Epilepsy , Intellectual Disability , Lymphangioleiomyomatosis , Myocytes, Smooth Muscle , Skin , Tuberous Sclerosis
11.
Tuberculosis and Respiratory Diseases ; : 293-300, 2011.
Article in Korean | WPRIM | ID: wpr-66615

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a substantially under-diagnosed disorder, and the diagnosis is usually delayed until the disease is advanced. However, the benefit of early diagnosis is not yet clear, and there are no guidelines in Korea for doing early diagnosis. This review highlights several issues regarding early diagnosis of COPD. On the basis of several lines of evidence, early diagnosis seems quite necessary and beneficial to patients. Early diagnosis can be approached by several methods, but it should be confirmed by quality-controlled spirometry. Compared with its potential benefit, the adverse effects of spirometry or pharmacotherapy appear relatively small. Although it is difficult to evaluate the benefit of early diagnosis by well-designed trials, several lines of evidence suggest that we should try to diagnose and manage patients with COPD at early stages of the disease.


Subject(s)
Humans , Early Diagnosis , Korea , Pulmonary Disease, Chronic Obstructive , Spirometry
12.
Tuberculosis and Respiratory Diseases ; : 397-404, 2011.
Article in English | WPRIM | ID: wpr-181455

ABSTRACT

BACKGROUND: To evaluate chest CT findings of pandemic influenza A/H1N1 pneumonia without co-infection. METHODS: Among 56 patients diagnosed with pandemic influenza A/H1N1 pneumonia, chest CT was obtained in 22 between October 2009 and Februrary 2010. Since two patients were co-infected with bacteria, the other twenty were evaluated. Predominant parenchymal patterns were categorized into consolidation, ground glass opacity (GGO), and mixed patterns. Distribution of parenchymal abnormalities was assessed. RESULTS: Median age was 46.5 years. The CURB-65 score, which is the scoring system for severity of community acquired pneumonia, had a median of 1. Median duration of symptoms was 3 days. All had abnormal chest x-ray findings. The median number of days after the hospital visit that Chest CT was performed was 1. The reasons for chest CT performance were radiographic findings unusual for pneumonia (n=13) and unexplained dyspnea (n=7). GGO was the most predominant pattern on CT (n=13, 65.0%). Parenchymal abnormalities were observed in both lungs in 13 cases and were more extensive in the lower lung zone than the upper. Central and peripheral distributions were identified in ten and nine cases, respectively. One showed diffuse distribution. Peribronchial wall thickening was found in 16 cases. Centrilobular branching nodules (n=7), interlobular septal thickening (n=4), atelectasis (n=1), pleural effusion (n=5), enlarged hilar and mediastinal lymph nodes (n=6 and n=7) were also noted. CONCLUSION: Patchy and bilateral GGO along bronchi with predominant involvement of lower lungs are the most common chest CT findings of pandemic influenza A/H1N1 pneumonia.


Subject(s)
Humans , Bacteria , Bronchi , Coinfection , Dyspnea , Glass , Influenza A Virus, H1N1 Subtype , Influenza, Human , Lung , Lymph Nodes , Pandemics , Pleural Effusion , Pneumonia , Pneumonia, Viral , Pulmonary Atelectasis , Thorax , Tomography, X-Ray Computed
13.
Tuberculosis and Respiratory Diseases ; : 226-230, 2010.
Article in Korean | WPRIM | ID: wpr-43649

ABSTRACT

Androgen deprivation therapy, which is the standard treatment for metastatic prostate cancer, includes nonsteroidal antiandrogenic drugs, such as flutamide, nilutamide and bicalutamide. Of them, bicalutamide rarely induces interstitial pneumonia. We report a case of bicalutamide-induced interstitial pneumonia. A 68-year old male diagnosed with prostate cancer and multiple bone metastases presented with dry cough and low grade fever for 3 days. He had taken bicalutamide (50 mg/day) for 13 months. High resolution computed tomography revealed ground glass opacity in his right upper lung. The laboratory studies showed no eosinophilia in the serum and bronchoalveolar lavage fluid. Despite the use of antimicrobial agents for 2 weeks, the extent of the lung lesions increased to the left upper and right lower lung. He had no environmental exposure, collagen vascular disease and microbiological causes. Under the suspicion of bicalutamide-induced interstitial pneumonia, bicalutamide was stopped and prednisolone (1 mg/kg/day) was initiated. The symptoms and radiologic abnormalities were resolved with residual minimal fibrosis.


Subject(s)
Humans , Male , Anilides , Anti-Infective Agents , Bronchoalveolar Lavage Fluid , Collagen , Cough , Environmental Exposure , Eosinophilia , Fever , Fibrosis , Flutamide , Glass , Imidazolidines , Lung , Lung Diseases, Interstitial , Neoplasm Metastasis , Nitriles , Prednisolone , Prostatic Neoplasms , Tosyl Compounds , Vascular Diseases
14.
Tuberculosis and Respiratory Diseases ; : 88-94, 2009.
Article in Korean | WPRIM | ID: wpr-178594

ABSTRACT

BACKGROUND: From November 2006, The national health insurance system in the Republic of Korea began to cover prescribed long-term oxygen therapy (LTOT) in patients with chronic respiratory insufficiency. This study examined the current status of LTOT after national health insurance coverage. METHODS: Between November 1, 2006 and June 30, 2008, the medical records of patients who were prescribed LTOT by chest physicians were reviewed. The data was collected from 13 university hospitals. RESULTS: 197 patients (131 male and 66 female) were prescribed LTOT. The mean age was 64.3+/-13.0 years. The most common underlying disease was chronic obstructive pulmonary disease (n=103, 52.3%). Chest physicians prescribed LTOT using arterial blood gas analysis or a pulse oxymeter (74.6%), symptoms (14%), or a pulmonary function test (11.2%). The mean oxygen flow rate was 1.56+/-0.68 L/min at rest, 2.08+/-0.91 L/min during exercise or 1.51+/-0.75 L/min during sleep. Most patients (98.3%) used oxygen concentrators. Only 19% of patients used ambulatory oxygen supplies. The oxygen saturation before and after LTOT was 83.18+/-10.48% and 91.64+/-7.1%, respectively. After LTOT, dyspnea improved in 81.2% of patients. The mean duration of LTOT was 16.85+/-6.71 hours/day. The rental cost for the oxygen concentrator and related electricity charges were 48,414+/-15,618 won/month and 40,352+/-36,815 won/month, respectively. Approximately 75% of patients had a regular visit by the company. 5.8% of patients had personal pulse oxymetry. 54.9% of patients had their oxygen saturation checked on each visit hospital. 8% of patients were current smokers. The most common complaint with LTOT was the limitation of daily activity (53%). The most common complaint with oxygen concentrators was noise (41%). CONCLUSION: The patients showed good compliance with LTOT. However, only a few patients used an ambulatory oxygen device or had their oxygen saturation measured.


Subject(s)
Humans , Male , Blood Gas Analysis , Compliance , Dyspnea , Electricity , Equipment and Supplies , Fees and Charges , Hospitals, University , Insurance, Health , Korea , Medical Records , National Health Programs , Noise , Oxygen , Pulmonary Disease, Chronic Obstructive , Republic of Korea , Respiratory Function Tests , Respiratory Insufficiency , Thorax
15.
Tuberculosis and Respiratory Diseases ; : 109-124, 2008.
Article in Korean | WPRIM | ID: wpr-158177

ABSTRACT

BACKGROUND: The incidence of chronic obstructive pulmonary disease (COPD) is increasing and the disease is becoming an important cause of morbidity and mortality worldwide. It is important to implement evidence-based guidelines by primary care physicians (PCPs) to establish qualified management of COPD patients. The aim of this survey is to investigate the pattern of COPD management among PCPs and to apply it to the development of Korean COPD guidelines. METHODS: A web-based questionnaire was prepared that consisted of 25 questions on the pattern of COPD management. A total of 217 PCPs participated in the survey from June 2006 to May 2007. RESULTS: Many PCPs (61.8%) possessed a spirometer, but the application rate was relatively low (35.8%) and more than half of the COPD patients (57%) did not receive a diagnosis based on spirometry. Administration of oral medication was preferred than the administration of inhaled medication for both stable COPD and acutely exacerbated COPD. More than 90% of the PCPs endorsed educational measures to quit smoking and vaccinate against influenza. It was noted that 56.7% of the PCPs were aware of the GOLD guidelines, but only 7.3% tended to fully implement the recommendations of the guidelines in daily practice. CONCLUSION: The results of the survey indicate that despite the high awareness rate of the current COPD guidelines, deficits exist among the PCPs with respect to the diagnosis and treatment of COPD. The results of this survey should be applied for the development of new COPD guidelines in order to decrease the discrepancy between the guidelines and the daily practice of the PCPs.


Subject(s)
Humans , Health Surveys , Incidence , Influenza, Human , Korea , Physicians, Primary Care , Primary Health Care , Pulmonary Disease, Chronic Obstructive , Surveys and Questionnaires , Smoke , Smoking , Spirometry
16.
Tuberculosis and Respiratory Diseases ; : 138-143, 2008.
Article in Korean | WPRIM | ID: wpr-223066

ABSTRACT

Pneumatosis intestinalis or spontaneous pneumomediastinum are rarely associated with nonspecific interstitial pneumonia (NSIP). However, the development of both conditions in the same patient simultaneously has not been reported previously. A 56-year-old man with NSIP developed spontaneous pneumomediastinum accompanied by subcutaneous emphysema and pneumatosis intestinalis after the treatment with intravenous high dose steroid. The development of spontaneous pneumomediastinum, subcutaneous emphysema and pneumatosis intestinalis in this patient was possibly due to the factors such as NSIP, high dose steroid therapy and subclinical dermatomyositis. Treatment with corticosteroid and cyclosporin gradually improved his exacerbated NSIP and pneumomediastinum, subcutaneous emphysema, pneumatosis intestinalis.


Subject(s)
Humans , Middle Aged , Cyclosporine , Dermatomyositis , Lung Diseases, Interstitial , Mediastinal Emphysema , Subcutaneous Emphysema
17.
Tuberculosis and Respiratory Diseases ; : 206-209, 2008.
Article in English | WPRIM | ID: wpr-77100

ABSTRACT

No abstract available.


Subject(s)
Bronchoscopy , Tuberculosis
18.
Tuberculosis and Respiratory Diseases ; : 309-313, 2008.
Article in Korean | WPRIM | ID: wpr-75869

ABSTRACT

Cytomegalovirus (CMV) pneumonia is a serious opportunistic infection in an immunocompromised host such as an AIDS patient or transplant recipient undergoing immunosuppressive therapy. Diffuse alveolar hemorrhage (DAH) is a relatively uncommon condition and it occurs most often in patients with systemic autoimmune disease. However, various types of infectious pneumonia with Mycoplsma hominis, Stenotrophomonas maltophilia and Pneumocystis jirovecii have been reported to be associated with the development of DAH. The association of CMV infection with the development of DAH has rarely been reported. We experienced a case of DAH associated CMV pneumonia and the patient was successfully treated with the use of antiviral agents and steroids.


Subject(s)
Humans , Antiviral Agents , Autoimmune Diseases , Cytomegalovirus , Cytomegalovirus Infections , Hemorrhage , Immunocompromised Host , Opportunistic Infections , Pneumocystis carinii , Pneumonia , Stenotrophomonas maltophilia , Steroids
19.
Tuberculosis and Respiratory Diseases ; : 356-361, 2008.
Article in Korean | WPRIM | ID: wpr-97156

ABSTRACT

BACKGROUND: We wanted to examine the clinical characteristics of adult patients with tracheobronchial foreign bodies (FBs) according to the risk of aspiration and the outcomes of intervention with using a fiberoptic bronchoscope. METHODS: From December 1994 through December 2004 at Kyung Hee Medical Center, we retrospectively analyzed the medical records of 29 adult patients with FBs that were identified by using a fiberoptic bronchoscope. RESULTS: 14 patients were not at risk of aspiration, whereas 15 had cerebrovascular diseases and they were at a high risk of aspiration. No history suggestive of FB aspiration was noted in 7 (24.1%) patients. Respiratory symptom(s) were noted in 22 patients, and these symptoms were cough (62.0%), dyspnea (44.8%), fever (20.7%), wheezing (13.8%), chest pain (10.3%) and hemoptysis (0.4%). Only 60% of those patients at a high risk of aspiration had symptom(s) (92.8% of those patients without a risk of aspiration had symptoms, p=0.005). Those patients at risk for aspiration had a longer duration of symptoms (median: 4 days vs. 2 days for those patients not at risk for aspiration, p=0.007) before diagnosis. Acute respiratory symptom(s) within 3 days after aspiration were more frequent in the patients without a risk of aspiration (9 vs. 4, respectively p=0.048). Chest x-ray revealed radiological abnormalities in 23 patients, and these were opacities suspicious of FB (n=11), pneumonia (n=8), air trapping (n=5) and atelectasis (n=3). There were no differences in radiological findings according to the risk of aspiration. FB aspiration developed most commonly during medical procedures (57.1% for the patients at risk) and during eating (35.7% for the patients without risk). The most common FB materials were teeth (n = 11). Alligator jaw biopsy forceps (n = 23) was the most commonly used equipment. All of the FBs were removed without significant complications. CONCLUSION: This study underlines that a tracheobronchial FB in the patients who are at a high risk of aspiration are more likely to overlooked because of the more gradual onset of symptoms and the symptoms develop iatrogenically in many cases.


Subject(s)
Adult , Humans , Alligators and Crocodiles , Biopsy , Bronchoscopes , Chest Pain , Cough , Dyspnea , Eating , Fever , Foreign Bodies , Hemoptysis , Jaw , Medical Records , Pneumonia , Pulmonary Atelectasis , Respiratory Sounds , Retrospective Studies , Surgical Instruments , Thorax , Tooth
20.
Tuberculosis and Respiratory Diseases ; : 8-14, 2008.
Article in Korean | WPRIM | ID: wpr-177323

ABSTRACT

BACKGROUND: Acinetobacter infections are difficult to treat as they often exhibit multiple resistance to the antibiotics that are currently available for the treatment of pneumonia. Colistin is active against gram-negative bacteria, including the multiple drug resistant (MDR) Acinetobacter species. However, intravenous administration of colistin was abandoned because of its nephrotoxicity and neurotoxicity. The aims of this study were to examine the efficacy and safety of colistin administered by aerosol in the treatment of pneumonia caused by MDR Acinetobacter baumannii. METHODS: We retrospectively reviewed the medical records of patients admitted to the intensive care unit (ICU) from Dec. 2006 to Aug. 2007 who had been diagnosed as suffering from pneumonia due to MDR Acinetobacter baumannii and had been treated with nebulized colistin. RESULTS: 31 patients received aerosolized colistin. The average duration of the treatment was 14+/-7 days and the daily dose of ranged from 225 mg to 300 mg. All patients received concomitant intravenous antimicrobial agents. The average length of the stay in the ICU was 34+/-21 days and in the hospital 58+/-52 days. The overall microbiological eradication was observed in 25 patients (80.6%). 14 of these (56%) were cured, and 11 (44%) were infected with other microorganisms. The overall crude mortality of the ICU was 48%. Nephrotoxicity and significant bronchial constriction did not occur in any patient during neublized colistin treatment. CONCLUSION: Nebulized colistin may be a safe and effective option in the treatment of pneumonia due to MDR Acinetobacter baumannii. Its role in therapy warrants further investigation in comparative studies.


Subject(s)
Humans , Acinetobacter , Acinetobacter baumannii , Acinetobacter Infections , Administration, Intravenous , Anti-Bacterial Agents , Anti-Infective Agents , Bronchoconstriction , Colistin , Gram-Negative Bacteria , Intensive Care Units , Medical Records , Pneumonia , Retrospective Studies , Stress, Psychological
SELECTION OF CITATIONS
SEARCH DETAIL